Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van bedrijfsleiders
Overzicht 
Founder of Reata Pharmaceuticals, Inc., Circuit Therapeutics, Inc. and Neucyte, Inc., Thomas C. SŁdhof is an entrepreneur who currently holds the position of Venture Partner at Catalio Capital Management LP, Scientific Advisory Board at Simcere Pharmaceutical Group Ltd., Scientific Advisory Board at Elysium Pharmaceuticals Ltd., Scientific Advisory Board at Alector, Inc. and Scientific Advisory Board at Jupiter Therapeutics, Inc.

He is also on the board of Sanofi and CytoDel LLC and Member of The Royal Society, Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, Member of National Academy of Medicine (United States), Member of Deutsche Akademie der Naturforscher Leopoldina eV, Professor at Stanford University School of Medicine and Member of The Royal Norwegian Society For Development.

In his past career he held the position of Member-Neuroscience Review Board at Genentech, Inc., Assistant Professor at The University of Texas Southwestern Medical Center and Research Assistant at Max Planck Institute For Biophysical Chemistry.

Thomas C. SŁdhof received a doctorate from RWTH Aachen University and an undergraduate degree from the University of Gottingen.


Posities en verantwoordelijkheden van Thomas C. SŁdhof 
NaamTitel Van
Sanofi
(Farmaceutische producten)
Independent Director 2016
Simcere Pharmaceutical Group Limited
(Farmaceutische producten)
Scientific Advisory Board -
Alector, Inc.
(Biotechnologie & Medisch Onderzoek)
Scientific Advisory Board -
CytoDel LLC Independent Director 2021
The Royal Society Member 2017
National Academy of Sciences Member 2002
American Academy of Arts & Sciences Member 2010
National Academy of Medicine (United States) Member 2007
Deutsche Akademie der Naturforscher Leopoldina eV Member 2015
Stanford University School of Medicine Professor -
The Royal Norwegian Society For Development Member -
Elysium Pharmaceuticals Ltd. Scientific Advisory Board -
Catalio Capital Management LP Venture Partner -
Jupiter Therapeutics, Inc. Scientific Advisory Board -


Thomas C. SŁdhofPersoonlijk netwerk 
Meest gelezen nieuws 
06/08ELON MUSK : Musk zegt dat Twitter-deal door moet gaan als hij bewijs levert van echte accounts
MR
10/08ELON MUSK : Elon Musk verkoopt 7,92 miljoen Tesla aandelen ter waarde van $6,9 miljard - SEC filing
MR
12/08MASAYOSHI SON : Met het terugbrengen van het aandeel in Alibaba koelt SoftBank's Son af ten opzichte van Chinese technologie
MR
04/08JACK DORSEY : Dorsey-leiding Block boekt verlies over tweede kwartaal
MR
03/08ELON MUSK : Twitter vraagt banken naar Musk's pogingen om $44 miljard deal te ondermijnen
MR
13/08ANSHU JAIN : Voormalig Deutsche Bank co-CEO Anshu Jain overlijdt - Bloomberg News
MR
01/08DAVID EINHORN : Greenlight van Einhorn neemt belang in Twitter - brief
MR
02/08STEPHEN KING : Horrorauteur Stephen King zegt in uitgeversproces dat consolidatie concurrentie schaadt
MR
01/08STEPHEN KING : Stephen King neemt het op voor de Amerikaanse overheid in een zaak tegen een mega-fusie van boekenuitgevers
MR
04/08ELON MUSK : Twitter verwerpt de beweringen van Musk dat hij werd misleid
MR
Meer nieuws


© 2022 People and Ownership :   
Thomas C. SŁdhof Verbindingen